A randomized phase III study evaluating dexamethasone-based mouthwash to prevent chemotherapy-induced stomatitis in patients with breast cancer

被引：0

作者：

Kuba, Sayaka ^{[1
]}

Soutome, Sakiko ^{[2
]}

Hagiwara, Yasuhiro ^{[3
]}

Kikawa, Yuichiro ^{[4
]}

Iwamoto, Takayuki ^{[5
]}

Sangai, Takafumi ^{[6
]}

Harao, Michiko ^{[7
]}

Yamaguchi, Takeshi ^{[8
]}

Taji, Tomoe ^{[9
]}

Igarashi, Ataru ^{[10
]}

Kajimoto, Yusuke ^{[10
]}

Sakurai, Naomi ^{[11
]}

Yamanouchi, Kosho ^{[12
]}

Watanabe, Kenichi ^{[13
]}

Maeda, Noriko ^{[14
]}

Suzuki, Masahiko ^{[15
]}

Maeda, Shigeto ^{[16
]}

Toh, Uhi ^{[17
]}

Ebata, Akiko ^{[18
]}

Iwakuma, Nobutaka ^{[19
]}

Matsunuma, Ryoichi ^{[20
]}

Yamaguchi, Miki ^{[21
]}

Mukai, Hirofumi ^{[22
]}

机构：

[1] Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg, 1-7-1 Sakamoto, Nagasaki 8528102, Japan

[2] Nagasaki Univ, Grad Sch Biomed Sci, Dept Oral Hlth, 1-7-1 Sakamoto, Nagasaki 8528102, Japan

[3] Univ Tokyo, Grad Sch Med, Dept Biostat, 7-3-1 Hongo,Bunkyo Ku, Tokyo 1130033, Japan

[4] Kansai Med Univ Hosp, Dept Breast Surg, 3-1 Shinmachi 2 Chome, Hirakata, Osaka 5731191, Japan

[5] Kawasaki Med Sch Hosp, Breast & Thyroid Surg, 577 Matsushima, Kurashiki, Okayama 7010192, Japan

[6] Kitasato Univ, Sch Med, Dept Breast & Thyroid Surg, 1-15-1,Kitazato,Minami Ku, Sagamihara, Kanagawa 2520375, Japan

[7] Jichi Med Univ, Dept Breast Oncol, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan

[8] Toranomon Gen Hosp, Dept Med Oncol, 2-2-2 Toranomon,Minato Ku, Tokyo 1058470, Japan

[9] Hyogo Prefectural Amagasaki Gen Med Ctr, Dept Breast Surg, 17-77 Higashinanba Machi, Amagasaki, Hyogo 6608550, Japan

[10] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Hlth Econ & Outcomes Res, 7-3-1 Hongo,Bunkyo Ku, Tokyo 1130033, Japan

[11] Canc Solut Inc, Tokyo, Japan

[12] Nagasaki Harbor Med Ctr, Dept Breast & Endocrine Surg, 6-39 Shinchi Machi, Nagasaki 8508555, Japan

[13] NHO Hokkaido Canc Ctr, Dept Med Oncol, 1-1,5-7 Yamanote,Nishi Ku, Sapporo, Hokkaido 0630005, Japan

[14] Yamaguchi Univ, Grad Sch Med, Dept Gastroenterol Breast & Endocrine Surg, 1-1-1, MinamiKogushi, Ube, Yamaguchi 7558505, Japan

[15] Kitamurayama Hosp, Breast Ctr, 2-15-1,Onsen Machi, Yamagata 9993792, Japan

[16] Nagasaki Rosai Hosp, Dept Surg, 12-5,Setogoe 2 Chome, Sasebo, Nagasaki 8570134, Japan

[17] Kurume Univ Hosp, Dept Breast Surg, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan

[18] Tohoku Univ, Grad Sch Med, Dept Breast & Endocrine Surg Oncol, 2-1,Seiryo Machi,Aoba Ku, Sendai, Miyagi 9808575, Japan

[19] NHO Kyushu Med Ctr, Breast Ctr, Dept Breast Surg, 1-8-1 Chigyohama, Fukuoka 8108563, Japan

[20] Shizuoka Prefectural Gen Hosp, Dept Breast Surg, 4-27-1,Kita Ando Aoi Ku, Shizuoka 4208527, Japan

[21] JCHO Kurume Gen Hosp, Dept Breast Surg, 21 Kushihara Machi, Kurume, Fukuoka 8300013, Japan

[22] Natl Canc Ctr Hosp East, Dept Breast & Med Oncol, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan

来源：

JAPANESE JOURNAL OF CLINICAL ONCOLOGY | 2024年

关键词：

stomatitis; chemotherapy; dexamethasone mouthwash; randomized controlled phase III trial; CYCLOPHOSPHAMIDE; EPIRUBICIN; DOCETAXEL; WOMEN;

D O I：

10.1093/jjco/hyae136

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Stomatitis, which is a common side effect of chemotherapy, currently lacks a standardized approach for its prevention. Therefore, this multicenter, randomized, open-label, controlled phase III trial aims to assess the efficacy and safety of a dexamethasone-based mouthwash for preventing chemotherapy-induced stomatitis in patients with early breast cancer. We will randomly assign 230 patients with early breast cancer scheduled to receive chemotherapy in a 1:1 ratio to either the dexamethasone-based mouthwash group (10 ml, 0.1 mg/ml; swish for 2 min and spit 4 times daily for 8 weeks) or the mouthwash-with-tap-water group. The incidence of stomatitis, measured using electronic patient-reported outcomes, is the primary endpoint. This randomized controlled phase III trial aims to evaluate the efficacy and safety of a dexamethasone-based mouthwash for preventing chemotherapy-induced stomatitis in patients with early breast cancer.

引用

页码：172 / 175

页数：6

共 50 条

[31] A Chinese version of the chemotherapy-induced alopecia distress scale based on reliability and validity assessment in breast cancer patients
Cong, WeiLian
Wu, YanNi
Liu, LiPing
Hu, MingYu
Zhou, ChunLan
SUPPORTIVE CARE IN CANCER, 2020, 28 (09) : 4327 - 4336
[32] Efficacy of cryotherapy on chemotherapy-induced peripheral neuropathy in patients with breast cancer: a propensity score-matched study
Xu, Min
Wang, Fan
Zhu, Xiaoli
Hao, Zhaohua
ANNALS OF MEDICINE AND SURGERY, 2023, 85 (06): : 2695 - 2703
[33] Hypoglossal acupuncture for acute chemotherapy-induced dysgeusia in patients with breast cancer: study protocol of a randomized, sham-controlled trial
Haller, Heidemarie
Wang, Taige
Lauche, Romy
Choi, Kyung-Eun
Voiss, Petra
Felber, Sabine
Cramer, Holger
Ataseven, Beyhan
Kuemmel, Sherko
Paul, Anna
Dobos, Gustav
TRIALS, 2019, 20 (1)
[34] Hypoglossal acupuncture for acute chemotherapy-induced dysgeusia in patients with breast cancer: study protocol of a randomized, sham-controlled trial
Heidemarie Haller
Taige Wang
Romy Lauche
Kyung-Eun Choi
Petra Voiß
Sabine Felber
Holger Cramer
Beyhan Ataseven
Sherko Kümmel
Anna Paul
Gustav Dobos
Trials, 20
[35] The Risk of Amenorrhea Is Related to Chemotherapy-Induced Leucopenia in Breast Cancer Patients Receiving Epirubicin and Taxane Based Chemotherapy
Zhou, Wenbin
Ding, Qiang
Liang, Xiuqing
He, Zhongyuan
Zha, Xiaoming
Liu, Xiaoan
Wang, Shui
PLOS ONE, 2012, 7 (05):
[36] A randomized trial to evaluate the impact of exercise-based cardiac rehabilitation for the prevention of chemotherapy-induced cardiotoxicity in patients with breast cancer: ONCORE study protocol
Diaz-Balboa, Estibaliz
Gonzalez-Salvado, Violeta
Rodriguez-Romero, Beatriz
Martinez-Monzonis, Amparo
Pedreira-Perez, Milagros
Palacios-Ozores, Patricia
Lopez-Lopez, Rafael
Pena-Gil, Carlos
Gonzalez-Juanatey, Jose R.
BMC CARDIOVASCULAR DISORDERS, 2021, 21 (01)
[37] Choice of study endpoint significantly impacts the results of breast cancer trials evaluating chemotherapy-induced nausea and vomiting
Ng, Terry
Mazzarello, Sasha
Wang, Zhou
Hutton, Brian
Dranitsaris, George
Vandermeer, Lisa
Smith, Stephanie
Clemons, Mark
BREAST CANCER RESEARCH AND TREATMENT, 2016, 155 (02) : 337 - 344
[38] Telpegfilgrastim for chemotherapy-induced neutropenia in patients with non-small cell lung cancer: a multicentre, randomized, phase 3 study
Shi, Yuankai
Wang, Xinshuai
Pei, Zhidong
Shi, Huaqiu
Zhang, Yanjun
Yi, Tienan
Mei, Jiazhuan
Guo, Yanzhen
Dong, Youhong
Ma, Tianjiang
Zhang, Qingyuan
Jia, Xiaojing
Zhu, Zhengqiu
Xu, Shen
Liu, Yanyan
Niu, Hongrui
Jiang, Weimei
Jiang, Xiaodong
Zhou, Shengyu
Sun, Li
BMC CANCER, 2025, 25 (01)
[39] Mechanisms and Genetic Susceptibility of Chemotherapy-Induced Cardiotoxicity in Patients With Breast Cancer
Mihalcea, Diana J.
Florescu, Maria
Vinereanu, Dragos
AMERICAN JOURNAL OF THERAPEUTICS, 2017, 24 (01) : E3 - E11
[40] Choice of study endpoint significantly impacts the results of breast cancer trials evaluating chemotherapy-induced nausea and vomiting
Terry Ng
Sasha Mazzarello
Zhou Wang
Brian Hutton
George Dranitsaris
Lisa Vandermeer
Stephanie Smith
Mark Clemons
Breast Cancer Research and Treatment, 2016, 155 : 337 - 344

← 1 2 3 4 5 →